Viewing nowPregabalin Capsule 75 mg (Pregabalin)
Pregabalin 75mg
Hard capsule · Prescription medication
Hawon Pharmaceutical Co., Ltd.

MFDS item code 201501153 · Approved 2015.03.06 · Insurance code 651503640
Treatment of neuropathic pain and fibromyalgia; adjunctive treatment of partial seizures in epilepsy
This medication is used for the treatment of peripheral and central neuropathic pain in adults. Additionally, it serves as an adjunct for epilepsy in adults, particularly for treating partial seizures with or without secondary generalized symptoms. It is also effective in relieving the symptoms of fibromyalgia. It works effectively on various neurological diseases and pain, improving the quality of life for patients.
This medicine should be administered orally as pregabalin in 2 divided doses per day, regardless of food. Since this medicine is eliminated primarily by the kidneys, the dose should be adjusted in patients with impaired renal function. (See section ‘5. Patients with renal impairment’) 1. Neuropathic pain 1) Peripheral neuropathic pain Adults: The starting dose of this medicine may be 150 mg per day. Based on the individual patient’s response and tolerability, the dose may be increased to 300 mg per day after 3 to 7 days. If necessary, it may then be increased at 7-day intervals to a maximum of 600 mg per day. 2) Central neuropathic pain Adults: The starting dose of this medicine may be 150 mg per day. Based on the individual patient’s response and tolerability, the dose may be increased to 300 mg per day after 1 week. After an additional week, it may be increased to the target daily dose of 600 mg. If the target daily dose is not tolerated, dose reduction may be considered. (See section ‘4. Discontinuation of treatment’) 2. Epilepsy Adults: The starting dose of this medicine may be 150 mg per day. Based on the individual patient’s response and tolerability, the dose may be increased to 300 mg per day after 1 week. If necessary, it may then be increased at 7-day intervals to a maximum of 600 mg per day. 3. Fibromyalgia The recommended dose of this medicine for fibromyalgia is 300 mg ~ 450 mg per day. The starting dose is 75 mg twice daily (150 mg per day), and based on efficacy and tolerability, it may be increased within 1 week to 150 mg twice daily (300 mg per day). For patients who do not experience sufficient benefit at a dose of 300 mg per day, the dose may be increased within 1 week to 225 mg twice daily (450 mg per day). Clinical studies have also been conducted at a dose of 600 mg per day, but there is no evidence of additional benefit or adequate tolerability at this dose. Given the dose-dependent adverse reactions, doses exceeding 450 mg per day are not recommended. 4. Discontinuation of treatment Based on current clinical experience, if treatment with this medicine is discontinued, it should be tapered gradually over at least 1 week. 5. Patients with renal impairment After systemic circulation, this medicine is excreted primarily by the kidneys as unchanged drug. Since clearance of this medicine is directly affected by creatinine clearance, dose reduction in patients with impaired renal function should be individualized based on creatinine clearance. Creatinine clearance [Table 1] is determined using the formula below. *: For women, multiply the result obtained from the above equation by 0.85. This medicine is effectively removed from plasma by hemodialysis (approximately 50% within 4 hours). In patients undergoing hemodialysis, the daily dose of pregabalin should be adjusted based on renal function. In addition to the daily dose based on renal function, a supplemental dose should be administered immediately after each 4-hour hemodialysis session. [Table 1]. Pregabalin dosage based on renal function TID = total daily dose divided into 3 doses BID = total daily dose divided into 2 doses QD = once daily a: The total daily dose (mg/day) should be divided as specified under the method of administration. b: The supplemental dose refers to a dose given as a single additional dose. 6. Patients with hepatic impairment No dose adjustment is necessary in patients with hepatic impairment. 8. Older adults (65 years and older) Dose reduction may be necessary in older adults with impaired renal function.
7. Pediatric and adolescent patients Administration is not recommended because there are insufficient safety and efficacy data for children under 12 years of age and adolescents aged 12 ~17 years.
This medication may increase the risk of suicidal thoughts or behaviors; if you experience mood changes or unusual behavior while taking it, you should consult your healthcare professional immediately. Patients with an allergy to any of the ingredients in this medication or with certain genetic lactose metabolism disorders should not take it. Diabetic patients should be cautious as weight gain may require adjustments in blood sugar control medications. If you experience facial or oral swelling (angioedema) as an allergic reaction, you should stop taking the medication immediately. Elderly individuals should be especially cautious when starting this medication due to the increased risk of falls or injuries from dizziness or drowsiness. Temporary blurring of vision or changes in vision may occur; if symptoms persist, consult your healthcare professional. Abrupt discontinuation of this medication may result in withdrawal symptoms such as insomnia, headache, nausea, and anxiety, so it should be gradually withdrawn under the guidance of a healthcare professional. Patients with a history of substance abuse may face a higher risk of abuse with this medication; consultation with a healthcare professional before use is advised. Patients with impaired kidney function should have their dosage adjusted and should have their kidney function status monitored regularly. Patients with severe heart disease should use this medication cautiously and should report any symptoms of heart failure to their healthcare provider immediately. Caution is needed when taking this medication with opioid analgesics due to an increased risk of central nervous system depression. Those with respiratory or neurological conditions or the elderly should be cautious as there is a high risk of severe respiratory depression while taking this medication. Pregnant women should avoid this medication during early pregnancy due to the risk of fetal malformation, and women of childbearing age should use effective contraception. Breastfeeding women should consult with their healthcare professional regarding whether to continue taking this medication, as it can be passed to breast milk and affect the infant. Activities requiring alertness, such as driving or operating machinery, should be avoided until dizziness or drowsiness subsides after taking this medication. Serious skin rashes or allergic reactions should prompt immediate discontinuation of the medication and notification to a healthcare provider. In the case of overdose, symptoms may include confusion, drowsiness, depression, and seizures; emergency treatment such as blood dialysis may be needed if necessary. This medication should be kept out of the reach of children and transferring to another container may pose a risk of accidents and degradation of quality.
Suicidal ideation, suicidal behavior, depression, abnormal changes in mood and behavior, angioedema, facial swelling, perioral swelling, upper airway swelling, dizziness, drowsiness, loss of consciousness, confusion, mental disorder, blurred vision, changes in vision, insomnia, headache, nausea, anxiety, diarrhea, influenza-like illness, restlessness, pain, seizures, hyperhidrosis, misuse, abuse, dependence, congestive heart failure, severe respiratory depression, rhinitis, neutropenia, increased appetite, decreased appetite, hypoglycemia, confusion, disorientation, irritability, euphoria, decreased libido, derealization, paraphilia, anxiety, mood swings, emotional lowering, emotional elevation, difficulty finding appropriate terms, hallucinations, abnormal dreams, increased libido, panic attacks, impulsivity, apathy, ataxia, motor coordination abnormalities, balance disorders, amnesia, attention deficit, memory impairments, tremors, dysphonia, sensory abnormalities, sensory loss, sedation, drowsiness, cognitive impairment, nystagmus, speech disorders, myoclonus, decreased reflexes, motor abnormalities, psychomotor agitation, positional dizziness, hypersensitivity, burning sensation, action tremor, syncope, confusion, movement disorders, olfactory disturbances, loss of taste, writing impairment, diplopia, loss of indirect vision, visual disturbances, visual field defects, photophobia, dry eyes, ocular edema, decreased vision, ocular pain, eye fatigue, increased tear secretion, ocular irritation, mydriasis, during vibration, changes in the depth of vision perception, strabismus, brightness of the visual field, dizziness, auditory hypersensitivity, first-degree atrioventricular block, tachycardia, sinus bradycardia, sinus tachycardia, sinus arrhythmia, hypotension, hypertension, flushing, facial flushing, peripheral coldness, dyspnea, epistaxis, cough, nasal congestion, rhinitis, snoring, pharyngeal tension, nasal dryness, respiratory depression, vomiting, abdominal distention, constipation, dry mouth, abdominal distension, hypersalivation, gastroesophageal reflux disease, oral sensory loss, ascites, dysphagia, pancreatitis, sweating, papular rash, urticaria, cold sweat, muscle cramps, arthralgia, back pain, limb pain, cervical spasms, joint swelling, myalgia, muscle spasms, neck pain, muscle rigidity, rhabdomyolysis, urination disorders, urinary incontinence, reduced urination, renal failure, erectile dysfunction, delayed ejaculation, sexual dysfunction, dysmenorrhea, amenorrhea, mastalgia, breast discharge, breast enlargement, peripheral edema, edema, gait abnormalities, falling, feeling drunk, altered sensation, fatigue, tightness in the chest, generalized edema, pain, fever, chills, weakness, thirst, weight gain, increased alanine aminotransferase, increased creatine phosphokinase, increased aspartate aminotransferase, increased blood sugar, decreased platelet count, decreased potassium levels, weight loss, increased serum creatinine, decreased white blood cell count, hypersensitivity, allergic reactions, headache, keratitis, pulmonary edema, nausea, diarrhea, tongue swelling, itching, Stevens-Johnson syndrome, toxic epidermal necrolysis, urinary retention, gynecomastia, lethargy, shock, anaphylaxis-like symptoms, mucous membrane syndrome, erythema multiforme, fatigue, weakness, gait abnormalities, sleep disturbances, constipation, gastrointestinal disturbances, bloody stools, increased BUN, dysuria, tinnitus, skin diseases, aggravated seizures, delirium, paralysis (facial paralysis), affective disorder, agitation, restlessness
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to protect it from air and moisture. The recommended storage temperature is between 15°C to 30°C. Proper storage will help maintain the medication's effectiveness and safety over time.
A hard capsule with a brown-red upper part and a white lower part containing a white powder.
30 capsules/bottle, 100 capsules/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowPregabalin 75mg
Hard capsule · Prescription medication
Hawon Pharmaceutical Co., Ltd.

Pregabalin 75mg
Hard capsule · Prescription medication
Viatris Korea Co., Ltd.

Pregabalin 150mg
Hard capsule · Prescription medication
Viatris Korea Co., Ltd.

Pregabalin 300mg
Hard capsule · Prescription medication
Viatris Korea Co., Ltd.

Pregabalin 150mg
Hard capsule · Prescription medication
Samjin Pharmaceutical Co., Ltd.

Pregabalin 75mg
Hard capsule · Prescription medication
Samjin Pharmaceutical Co., Ltd.

Pregabalin 75mg
Hard capsule · Prescription medication
Hanmi Pharm. Co., Ltd.

Pregabalin 150mg
Hard capsule · Prescription medication
Hanmi Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.